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1. Introduction 
Concomitant diseases were defined as those detected during the preoperative diagnostic 
evaluation for symptomatic abdominal aortic aneurysm (AAA) or occasional finding during 
oncological staging and/or follow-up, or as an intraoperative unsuspected findings at 
laparotomy. Malignancies presenting synchronously with AAA more frequently include 
primary or metastatic cancer of the gastrointestinal or genitor-urinary systems; more 
anecdotally, lung or endocrine cancers have been reported to be treated with AAA repair. 
The association of AAA and malignancies is rare. In fact, although the true incidence of 
concomitant malignancy and AAA is difficult to establish, most centers report a low 
incidence of co-existence: discrepancy in incidence between the various studies probably 
depends on whether all aneurysms are included or just those operated on, and also whether 
only simultaneously diagnosed malignancies are included or all malignancies associated 
with a patient with an AAA (Jibawi et al., 2011). Malignancies were found in 4% of AAA 
cases in an extensive experience that covered 22 years (Szilagyi et al.). In the UK in 1995 
there were approximately 7000 elective and emergency operations for AAA, giving an 
estimated annual incidence of concomitant colorectal malignancy of between 35 and 105 
(Morris et al. 1998). 
Since the milestone report of Szilagyi’s four decades ago (Szilagyi et al.), surgical procedures 
for synchronous AAA and tumors have been constantly performed but reports have been 
mainly represented by single case series with small numbers. More recently, the advent of 
mini-invasive technology have (potentially) widened the indication to treat both lesions 
more extensively. A simultaneous minimally invasive treatment should be intended as the 
single-stage operation that couples an endovascular treatment to exclude the AAA and an 
additional minimally invasive technique to treat or excise the concomitant malignant lesion. 
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2. Radiologic work-up and patient selection 
 Regardless of the type of tumor, a multidisciplinary team help to direct the work-up and 
choose the type of imaging studies to determine AAA repair as well as the resectability of 
the cancer.  
The goals of the radiologic work-up are the following items: 
 to confirm the diagnosis and specify the morphology and sizing of the AAA 
 define the local extent of the malignancy and the presence of metastases 
When possible, preoperative evaluation should be  carried out following a specific protocol, 
performing routine preoperative blood test, chest X-rays, ECG transthoracic 
echocardiography, plethymsography, and thoraco-abdominal CT-angiography (Fig. 1). 
 
 
Fig. 1. Preliminary CT-angiography showing the presence of a mass (A, arrow) protrusing 
from the upper portion of the right kidney (B, dotted line) and a huge 6.5cm fusiform 
infrarenal AAA (C) 
Esofagogastroscopy and/or flexible colonoscopy, liver ultrasound and other staging 
examinations were performed depending on the location of the tumor. The combination of 
these studies is needed to determine surgical resectability and to plan the type of 
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reconstruction, and therefore to guide the type of surgical approach and to assess the 
feasibility of the mini-invasive approaches. 
Pathologic tumor staging should be classified according to the most recent TNM system.  
Post-operative follow-up should be scheduled at periodic intervals (generally, 1, 6 and 12 
months) coupling clinical visit, serological tests using oncologic markers, and CT-
angiography to confirm the technical success or detect any type of complications (Fig. 2). 
 
 
Fig. 2. Follow-up CT-angiography detecting an early type 2 endoleak (B, arrows) because of 
the inverted flow into the inferior mesenteric artery (A) 
For decades, surgical intervention were rarely performed for several reasons: many 
cancers presented in advanced stage and carried poor prognosis, extent of the procedure 
especially for debilitated patients who had associated co-morbidities that placed them at 
high operative risk, many patients had undergone previous attempts of surgical resection 
or received adjuvant chemotherapy or radiation therapy that increased technical 
difficulties. More recently, improvements in preoperative imaging studies, surgical 
techniques, intraoperative anesthetic management, postoperative care, and the success of 
prosthetic grafts have burdened the impetus for a more aggressive surgical approach in 
selected patients. Nowadays, those patients with localized tumor, few co-morbidities (e.g. 
renal, liver, cardiopulmonary), and a good performance status could be considered 
candidates for operation. Careful patient evaluation is critical to outcome; a 
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multidisciplinary approach to the evaluation and treatment of these patients is an integral 
component for patient selection involving both the medical evaluation of the candidate 
along with a precise assessment of both AAA and tumor extension. Dealing with a similar 
clinical challenge, such as the combination of liver resection with caval vascular 
reconstruction, a patient's performance status could be determined using general criteria 
which provides an assessment of the patient's physical conditioning and has been a useful 
measure of functional quality of life for patients with malignant disease in that situation 
(Bower et al, 2000). 
3. Indication 
All agree that definitive treatment of both processes confers the best overall prognosis; 
nevertheless, concerns still remain toward decision-making strategy, whether it is better to 
treat both diseases simultaneously or as staged procedures. Clinical consensus is to treat the 
most life-threatening process first: prioritization is determined by the urgency of addressing 
each of the identified conditions (Kiskinis et al., 2004). In the past, surgical strategy was 
determined by the patient’s general condition, the patient’s symptoms, the surgeon’s 
preference, the AAA size, and cancer stage. 
Up to date, we have paucity of experiences with small number of cases treated, with wide 
heterogeneities of the oncologic lesions: hence, because of all these uncertainties, there is no 
consensus on the best therapeutic approach for patients with simultaneous AAA and 
malignancy. In addition, detailed management strategies vary however, among different 
authors with some choosing simultaneous over sequential operations on the basis of cancer 
type and stage (Oshodi et al., 2000). 
The main goal of the single-stage is either to prevent cancer progression or to prevent AAA 
rupture; the advantages of the simultaneous intervention are clear: 
 treating two lethal diseases with a single laparotomy reduces technical difficulties due 
to scarred or post-attinic tissues; 
 the specific risk related to general anaesthesia, particularly high in these patients often 
affected by significant co-morbidities (vascular, respiratory and metabolic) and the 
advanced age, it is reduced by treating both condition at one time; 
 the risk of cancer progression is kept at minimum since there is no delay between 
tumour diagnosis and surgical treatment 
The main disadvantage of the combined intervention is that single-stage operation carries 
potential risk of graft infection; in addition, it lengthens the operation time and decreases 
the bowel perfusion. 
The advantages of the delayed intervention are: 
 lower risk of graft infection due to the reduced risk of septic disease 
 it reduces splanchnic ischemia (reduces potential leakages of the gastrointestinal or 
genitor-urinary anastomosis) 
 it allows a definitive and specific staging of the oncologic disease 
The main disadvantage of the two-stage intervention is that when AAA repair is 
performed first, the physiological immunosuppression effect can lead to cancer 
progression, whereas it has been demonstrated that, when the malignant tumour is 
resected first, there is a systemic release of protheolytic enzymes that could lead to the 
growth and rupture of the aneurysmatic sac (Lin et al., 2008). In addition, it is 
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unquestionable that the two stage approach is definitively technically more complex due 
to the presence of peritoneal adhesions that, in some patients, could be extremely hard to 
dissect.  
4. Intervention techniques 
Generally, in conventional AAA repair a standard transperitoneal approach using a midline 
laparotomy has been performed; few Authors suggested a retroperitoneal approach to avoid 
contamination (Grego et al., 2003). Surgical reconstruction of the AAA have been 
preferentially performed using Dacron graft: silver or antibiotic-bonded prostheses should 
be supported in order to reduce the risk of infection in a potentially contaminated fields. 
Cancer resection was carried out following the main oncological principles (no touch 
techniques and vessels legation at their origins). 
With the availability of laparoscopic surgery, as well as other minimally invasive therapies 
such as cryoablation for conditions including renal lesions, endovascular aortic repair 
(EVAR) nowadays represents an attractive alternative treatment modality with a less 
traumatic strategy (Porcellini et al., 2007). In addition to the management of primary AAAs, 
late sequelae of traditional repair such as anastomotic aneurysm, can also be addressed. 
Endografting confers the benefit of eliminating the need for a second laparotomy and 
creates flexibility in managing concomitant malignancy in rapid succession or 
simultaneously (Lee et. al, 2002). The devices can be placed prior to transabdominal 
resection and thus post-laparotomy rupture can be avoided. Hence, more recently, the 
single stage approach has been proposed using EVAR: the availability of this minimally 
invasive treatment strategy has created an alternative therapeutic paradigm, particularly in 
patients with synchronous challenging settings (Rivolta et. al, 2007). Results are still 
preliminary, and paucity of documentation exists concerning the application of EVAR to 
these patients as well as data pertaining to perioperative events. 
Very few data have been published on the outcomes of synchronous treatment of AAA and 
tumors: we should take into account that the different etiology of cancers and the small 
number of patients preclude definitive conclusions regarding survival for such extensive 
interventions performed with open surgery. The advent of minimally invasive techniques 
with their encouraging results have been recently confirmed from different teams; in 
particular, EVAR intuitively should offer clinical and postoperative survival benefits in 
those patients at higher risk for conventional open repair. However, concerns remain about 
the definition of high-risk patient. Is the patient with concomitant diseases at higher risk for 
mini-invasive operations? In previous clinical experiences, ASA score have been used to 
identify high-risk patients; this is a variable objectively assessed by an independent auditor 
(anesthesiologist); it has been reported a 7.8% hospital mortality for ASA class 4, a 15-times 
higher than the rate for low-risk patients in that center (Verzini et al., 2002). If we consider 
the results of a large pivotal trial, attempt to identify the predictors of survival we could 
observe that malignancy was the cause of death in 30% of the patients, overall especially in 
the second year of that experience (Matsumura et al., 2009). More recently, our results have 
been in consonance with these data: in the long-term analysis, ASA was an independent 
factors of mortality but we did not consider the stage of malignant disease in the concept of 
high-risk patient despite tumors cancer was the second leading cause of death (11%) in our 
personal series (Lomazzi et al., 2011). 
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5. Literature review 
The first ever report of minimally invasive treatment of synchronous malignancy and 
AAA was reported in 1998 by Herald et al. who performed full rectal wall thickness 
endoanal local excision of the rectal tumor but delayed the EVAR of the aneurysm three 
weeks later (herald et al., 1998). Similarly, Hafez et al. reported 3 cases of combined 
treatment for kidney tumors and AAA, but again the Authors did go 97 days between the 
two procedures (hafez et al., 2000). The most extensive clinical experience in the surgical 
management of patients with synchronous AAA and colo-rectal cancer have been 
reported by Lin et al. over 108 cases (lin et al., 2008). In their data, a total of 92 patients 
formed the basis of the study: twelve patients underwent EVAR but they were primarily 
treated for the AAA and then the colo-rectal cancer followed. They had no aortic graft 
infections, regardless of whether surgical treatment was performed in a staged or 
simultaneous fashion; however, they stated that despite the reported safety by several 
researchers about combined surgical repair of these synchronous lesions, we believe such 
a simultaneous surgical approach should be avoided whenever possible. It reflected the 
relatively small sample size in each group, rather than the safety of various treatment 
modalities. They concluded suggesting that: 1) staged open AAA repair followed by colo-
rectal excision should be performed with caution because of the higher operative 
morbidity and mortality rates; 2) although combining rectal resection with EVAR during a 
single operation may seem to be an attractive option, concerns still remain about the 
potential endograft infection because of the seeding from the perioperative bacteremia 
related to the colon resection. 
The attractive alternative to repair in a single-stage operation both lesions was brought to 
the fore by Lee et al. in 5 patients with different malignancies including renal, urinary 
bladder, esophageal, lung, and prostate (Lee et al., 2002). Endovascular exclusion was 
successfully accomplished in all cases, and surgical conversions were never needed; the 
postoperative course was uneventful with mean length of stay was 3.4 days. The Authors 
concluded that EVAR of either an aneurysm or other aortic pathology in patients with an 
associated malignancy can be performed safely, but remains an individualized option with a 
multidisciplinary team necessary to explore this type of approach. 
The advantage of EVAR repair in patients with different (colon-rectum, bladder, pancreas, 
esophagous, prostate, kidney) concomitant abdominal malignancy was finally highlighted 
in a recent report by Porcellini et al. who compared 14 patients undergoing conventional 
open AAA repair vs. 11 patients who received endografting (Porcellini et al., 2007). 
Among those who received conventional open repair, 7 patients had simultaneous 
operations, with operative mortality and aortic graft infection rates of 14% and 14%, 
respectively. The overall operative morbidity and mortality rates of those treated with 
conventional open aneurysm repair were 34% and 21%, respectively. This was in contrast 
to the EVAR patient cohorts, who suffered no operative mortality and a relatively low 
operative morbidity rate of 8%. These short-term benefits are extremely important in 
patients who require further treatment for the concomitant oncologic lesion; even an 
advantage that was maintained after a mean follow-up of approximately 3 years. 
Furthermore, it is also likely that improvement of endovascular devices, refined 
technique, and enhanced operator experience will have an impact on the long-term 
outcome of EVAR. 
www.intechopen.com
Concomitant Abdominal Aortic Aneurysm and  
Malignancy: Simultaneous Minimally Invasive Repair 
 
307 
6. Personal experience 
Between august 1989 and December 2010, our overall  experience consisted of 31 cases of 
synchronous repair of AAA and malignancy using the single-stage approach. The single 
stage minimally invasive approach was performed in 10 cases: we operated 9 males and 1 
female, with a median age of 72 years (range 52-79). Most of the patients had co-
morbidities: hypertension (n = 9), ischemic heart disease with prior cardiac 
revascularization (n = 4), chronic obstructive pulmonary (FEV1 < 1lt, n = 4), and mild 
(creatinine >2mg/dL) chronic renal insufficiency (n = 1). Oncologic lesions included colo-
rectal cancer (n = 5), kidney (n = 2), adrenal gland (n = 1), liver metastasis (n = 1), and 
lung cancer (n =1). Aortic disease included atherosclerotic fusiform AAA (n = 9), and 
saccular aneurysm complicating an ulcerated plaque (n = 1). All AAAs were infra-renal 
with a mean diameter of 58 mm (range, 44-92). Aneurysms were treated using bifurcated 
(n = 9) or tube (n = 1) endograft (infrarenal n = 8, transrenal n = 2). Oncologic operations 
included laparoscopic colectomy (left n = 4, right n = 1) for colo-rectal cancers, 
thermoablation with radiofrequency (n = 3), laparoscopic right nephrectomy (n = 1), and 
thoracoscopic wedge resection (n = 1). The mean blood loss was 312 ± 54 ml (range 154-
400). Intensive care unit was never needed. Two patients had a major postoperative 
complication: acute on chronic renal insufficiency (n = 1) but hemofiltration or dialysis 
were not required, and acute pulmonary oedema (n = 1). Hospital mortality was not 
observed; there was no evidence of perioperative endograft infection. Mean 
hospitalization was 7 days (range 4-12). All patients were discharged alive and well; no 
patient was lost to follow-up. Median follow-up was 14 months: endograft infection was 
never observed, 2 patients died because of disseminated cancer disease (liver) and 
pulmonary thromboembolism without clinical or radiological signs of recurrency 
(kidney). 
7. Comment 
While co-existing AAA and malignancy is not a common problem, it presents a challenging 
dilemma in terms of operative management. Most physicians agree that treatment priority 
should be focused on the symptomatic or more life threatening lesion (Baxter et al., 2002). 
But because the majority of these concomitant lesions are asymptomatic at the time of 
diagnosis, physicians frequently are confronted with a therapeutic dilemma when dealing 
with this potentially challenging surgical problem. When the vascular surgeon discovers 
intra-abdominal malignancy before or during laparotomy the main considerations are to 
treat both lesions effectively, and to minimize the risks of graft infection and of 
postoperative rupture of the aneurysm. 
The simultaneous combined treatment has not been used extensively; Literature lacks of 
experiences, especially those with long-term follow-up (Table 1). 
Less often minimally invasive techniques have been used to treat concomitant lesions in a 
single-stage intervention. This because it has been considered inappropriate to resects 
aneurysms less than 50 mm or less in diameter, synchronously with a major gastrointestinal 
lesion if they are asymptomatic (Matsumoto et al., 1999). However, we should also pointed 
out that literature reported worse outcomes for patients with larger aneurysms, because 
they are often associated with a less favorable anatomy for EVAR (Zarins et al., 2006). In 
contrast, given the excellent results of EVAR in the short-term period in terms of morbidity 
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and mortality, coupled with the most recent endograft improvement, as well as the shorter 
life-expectancy of these patients and the need to receive adjuvant therapies for the 




The main critic against a synchronous repair has been believed to be the increased risk of 
graft infection; to tell the truth, several previous papers focused on the outcome of a 
simultaneous intervention for AAA and cancer finally did not highlighted an increased risk 
for this type of complication. The risk of direct graft contamination by gut or urinary tract 
bacterial agents may be reduced by a combination of preoperative and bowel preparation, 
meticulous surgical technique and antimicrobial therapy with long-term antibiotic 
prophylaxis. Moreover, endograft placement should theoretically prevent exposure of the 
graft to an infected or potentially contaminated operative field: in fact, laparotomy is 
avoided and the aneurysmatic sac potentially protects the endograft from bowel 
contamination because of contiguity. In addition, septic complications following EVAR has 
been reported in only 0.43%, still lower than the 0.5-3% of the conventional open repair 
(Ducasse et al., 2004). 
It is unquestionable whether the single-stage intervention using minimally invasive 
techniques has technically decreased complexity and less traumaticity. Intuitively, it 
remains desirable but even doubtful that a prospective randomized controlled study with 
sufficient statistical power will ever take place to definitively formulate a standardized 
treatment strategy in patients with these concomitant diseases. 
8. Conclusion 
Lacks of extensive series as well as long-term follow-up do not allow to drawn definitive 
conclusions. Simultaneous AAA repair and malignancy excision using minimally invasive 
techniques has been rarely reported in a single-stage operation. Nevertheless, the few 
papers actually available reported encouraging technical and clinical results especially in the 
short-term period, provided that aortic anatomy is suitable. If this is the case, it may be 
considered an attractive alternative to standard open repair. 
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